TriSalus Life Sciences (TLSI) Cash & Equivalents (2022 - 2025)
Historic Cash & Equivalents for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $22.7 million.
- TriSalus Life Sciences' Cash & Equivalents rose 10098.33% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.7 million, marking a year-over-year increase of 10098.33%. This contributed to the annual value of $8.5 million for FY2024, which is 2761.31% down from last year.
- As of Q3 2025, TriSalus Life Sciences' Cash & Equivalents stood at $22.7 million, which was up 10098.33% from $26.5 million recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' Cash & Equivalents registered a high of $26.5 million during Q2 2025, and its lowest value of $50930.0 during Q1 2022.
- Over the past 4 years, TriSalus Life Sciences' median Cash & Equivalents value was $9.4 million (recorded in 2022), while the average stood at $9.7 million.
- Over the last 5 years, TriSalus Life Sciences' Cash & Equivalents had its largest YoY gain of 1575092.57% in 2024, and its largest YoY loss of 4721.04% in 2024.
- Over the past 4 years, TriSalus Life Sciences' Cash & Equivalents (Quarter) stood at $9.4 million in 2022, then rose by 25.1% to $11.8 million in 2023, then fell by 27.61% to $8.5 million in 2024, then surged by 166.12% to $22.7 million in 2025.
- Its Cash & Equivalents stands at $22.7 million for Q3 2025, versus $26.5 million for Q2 2025 and $13.0 million for Q1 2025.